文献速递质量管理与危急值临床生化

CRESS清单:稳定性研究报告规范(EFLM WG-PRE)

The CRESS checklist for reporting stability studies: on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE).
PubMed 文献 · Clin Chem Lab Med · 2020-07-25

欧洲临床化学与实验室医学联合会检验前阶段工作组(EFLM WG-PRE)通过详细文献回顾与广泛讨论达成共识,制定CRESS清单,用于规范和报告分析物稳定性研究。清单含20个条目,覆盖稳定性研究报告应考虑的各方面,并说明每个条目应报告的内容及理由。遵循该清单可使研究报告透明、可重复,便于其他实验室评估数据是否适用于自身医疗场景。

要点

  • CRESS清单共20个条目,覆盖稳定性研究报告应包含的全部要素。
  • 遵循清单可保证报告透明且可重复,便于评估数据向其他医疗场景的可迁移性。
  • EFLM WG-PRE建议将CRESS清单用于稳定性研究的规划与标准化报告。

核心结论

  • EFLM WG-PRE制定CRESS清单(含20个条目),用于规范稳定性研究的报告,保证报告透明、可重复并便于评估可迁移性。

研究设计与样本

  • EFLM WG-PRE基于详细文献回顾与广泛讨论达成共识,制定CRESS清单。

主要发现

  • 现有稳定性研究与数据库虽多,但缺乏开展和报告稳定性研究的指南,导致研究常遗漏关键信息,影响数据可迁移性。
  • CRESS清单含20个条目,覆盖稳定性研究报告应考虑的各方面,并说明各条目应报告的内容及理由。

关键数值与推荐

  • 清单共20个条目,逐条给出应报告的内容及理由(原文未给出具体条目细节)。

临床怎么用

  • 研究者与作者可用CRESS清单指导稳定性研究的设计,并对未来稳定性研究进行标准化报告。
  • 其他实验室可据此评估已发表数据是否满足本机构医疗场景所需的稳定性标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

To ensure that clinical laboratories produce results that are both accurate and of clinical utility it is essential that only samples of adequate quality are analysed. Although various studies and databases assessing the stability of analytes in different settings do exist, guidance on how to perform and report stability studies is lacking. This results in studies that often do not report essential information, thus compromising transferability of the data. The aim of this manuscript is to describe the Checklist for Reporting Stability Studies (CRESS) against which future studies should be reported to ensure standardisation of reporting and easy assessment of transferability of studies to other healthcare settings. The EFLM WG-PRE (European Federation of Clinical Chemistry and Laboratory Medicine Working Group for the Preanalytical Phase) produced the CRESS checklist following a detailed literature review and extensive discussions resulting in consensus agreement. The checklist consists of 20 items covering all the aspects that should be considered when producing a report on a stability study including details of what should be included for each item and a rationale as to why. Adherence to the CRESS checklist will ensure that studies are reported in a transparent and replicable way. This will allow other laboratories to assess whether published data meet the stability criteria required in their own particular healthcare scenario. The EFLM WG-PRE encourage researchers and authors to use the CRESS checklist as a guide to planning stability studies and to produce standardised reporting of future stability studies.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Cornes M, Simundic AM, Cadamuro J, et al. The CRESS checklist for reporting stability studies: on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE). Clin Chem Lab Med. 2020. PMID: 32710715. doi:10.1515/cclm-2020-0061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。